A quality agreement is the document that allocates GMP responsibilities between a marketing authorization holder and the external parties that manufacture, package, label or test its product. It is required practice across regulated markets, it is reviewed in inspections, and it is one of the few commercial documents where a gap translates directly into a compliance finding rather than a cost.
It is also a document that ages badly. The responsibility matrix is negotiated during qualification, when both parties are attentive and the scope is fresh. Two years later the contract manufacturer has changed a supplier of an excipient, moved an analytical method to a different site, and taken on a subcontractor for secondary packaging. The matrix on file still describes the original arrangement.
This datasheet describes what a working quality agreement tracking capability maintains, how it connects to the commercial supply agreement, and what it produces when an inspector asks who is accountable for a specific activity.
What the tracking layer maintains
Quality agreement tracking is less about storing the document than about keeping a set of structured facts current and evidenced. The following are the records that inspections and internal quality reviews consistently ask for.
- Responsibility matrix by activity, which party performs, which approves and which is notified, at the level of individual GMP activities rather than broad categories
- Agreement linkage, an explicit link between each quality agreement and the commercial supply agreement it accompanies, including amendment history for both
- Change notification obligations, the categories of change requiring notification or prior approval, with the contracted notice window and the current status of each open notification
- Deviation and complaint duties, reporting routes, timelines and escalation thresholds for deviations, out-of-specification results and product complaints
- Audit and requalification schedule, the contracted audit frequency, last audit date, open findings and next scheduled requalification for each site and activity
The responsibility matrix is where most of the operational value sits. Held as structured records rather than as a table inside a document, it can be queried, which means a quality lead can answer who is responsible for a specific activity across the whole network in a single view, rather than opening forty agreements and reading tables.
Manufacturing networks change continuously. Sites add subcontractors, methods transfer, suppliers are requalified. The question is not whether the responsibility matrix will diverge from practice but how quickly the divergence is detected. A tracked change notification obligation with a defined window is what turns that from an inspection finding into routine maintenance.
How the quality agreement connects to commercial terms
Quality agreements and supply agreements are usually negotiated by different functions, signed at different times, and stored in different systems. That separation is the source of a recurring class of problem.
- Inconsistent amendment. A commercial amendment that changes scope, volume or site can leave the quality agreement describing an arrangement that no longer exists.
- Conflicting termination terms. Supply agreements and quality agreements frequently carry different notice periods, which becomes acute during an exit when GMP responsibilities must continue past commercial termination.
- Divergent audit rights. Audit provisions appear in both documents and are often drafted independently, producing two different frequencies and scopes for the same relationship.
- Subcontractor flow-down gaps. The commercial agreement may permit subcontracting that the quality agreement does not address, leaving the responsibility allocation silent on a party actually performing GMP work.
- Retention mismatches. Records retention obligations under the quality agreement commonly outlast the commercial relationship, and need to survive termination expressly.
A five-step rollout across the manufacturing network
Step 1, Inventory agreements and pair them
Build a list of every external party performing GMP activity, and pair each quality agreement with its commercial supply agreement. Unpaired quality agreements and supply agreements with no corresponding quality agreement are both findings waiting to happen, and the inventory is usually the step that surfaces them.
Step 2, Extract the responsibility matrix
Convert the matrix in each agreement into structured records at activity level. This is effortful the first time and is what makes every subsequent query possible. Use a single activity taxonomy across the network so that agreements from different eras and different negotiating teams become comparable.
Step 3, Load notification and reporting obligations
Capture change notification categories, notice windows, deviation reporting timelines and complaint routes as tracked obligations with owners. Attach the contracted window to each so that an open notification can be measured against it rather than assessed by memory.
Step 4, Schedule audits and requalification
Load contracted audit frequency, last completed date and open findings for every site and activity. Overdue audits against a contracted frequency are among the most straightforward findings for an inspector to establish, and among the easiest to prevent.
Step 5, Report the network, not the document
Produce a single view of responsibility coverage, open notifications against window, audit status and agreement-pair consistency across all partners. This is the artifact that supports both internal quality review and inspection readiness.
See responsibility allocation across the whole network
Aavenir holds quality agreement terms as structured records, links them to the governing supply agreements, and tracks notification and audit obligations with owners and dates.
What this produces during an inspection
The practical test of a quality agreement program is what can be produced on request. An inspector asking who is responsible for a given activity at a given site expects a definitive answer supported by a current, signed agreement, not a search through a document store. A tracked responsibility matrix answers that in one query and shows the amendment history behind it. The same structure answers the follow-up questions that usually come next: whether the contracted audit frequency has been met, whether open change notifications are within their windows, and whether the quality and supply agreements describe the same arrangement. Organizations that already run structured GxP audit evidence through their contract platform find this is an extension of work already done rather than a separate program. The difference an inspector notices is response time. A team that produces a current responsibility matrix, its amendment trail and the matching audit record within minutes is demonstrating a controlled process, while a team that needs a day to assemble the same facts is demonstrating that the control exists on paper rather than in operation.
Quality agreement coverage by partner type
Not every external party needs the same depth of agreement. Scope should follow the GMP activity performed, and the table below reflects the coverage that regulated manufacturers typically maintain.
| Partner type | Core matrix content | Typical audit cadence |
|---|---|---|
| Contract manufacturer, drug product | Manufacture, in-process control, batch release, deviation handling | Every one to two years, risk-based |
| API manufacturer | Synthesis, impurity control, specification change, stability | Every two to three years, risk-based |
| Contract testing laboratory | Method validation, OOS handling, data integrity, result reporting | Every two years, or on method transfer |
| Packaging and labeling | Artwork control, serialization, reconciliation, market release | Every two to three years |
| Storage and distribution | Temperature control, deviation reporting, traceability, recall support | Every two to three years |
Quality agreements are among the few commercial documents that a regulator will read in detail. Keeping them accurate is not a records management preference, it is the evidence that GMP responsibilities are allocated, understood and being performed by the party that agreed to perform them. Holding the responsibility matrix as structured data, linking it to the commercial agreement it accompanies, and tracking notification and audit duties through obligation management turns that evidence from something assembled under pressure into something available on demand. It also makes the routine work cheaper, since the quality lead reviewing partner coverage each quarter is reading a report rather than reopening forty agreements.
For related guidance, see The quality leader’s guide to CMO quality agreements, Quality agreement tracking for sponsors and CDMOs and Quality agreement obligations, who tracks what in GxP.
